A study published in Critical Care proposes that septic shock patients could benefit from a more measured approach to fluid resuscitation, moving away from a focus on fluid responsiveness and instead targeting signs of fluid intolerance. The research examined whether adjusting fluid administration based on harm indicators could enhance oxygenation while avoiding tissue perfusion deterioration. Fluid resuscitation is a fundamental component of septic shock management, but determining how much fluid to administer remains a persistent challenge in intensive care. Although intravenous fluids can improve cardiac output and tissue perfusion, excessive administration may contribute to pulmonary edema, venous congestion, and organ dysfunction.
Septic shock treatment has traditionally depended on intravenous fluids to maintain blood flow and organ function. Existing protocols emphasize fluid responsiveness—the ability to increase cardiac output after fluid delivery—but this approach fails to address patients who may still develop harmful effects despite appearing responsive. The study introduced a distinction between fluid responsiveness and fluid tolerance: fluid responsiveness describes the cardiovascular system’s ability to increase stroke volume after fluid administration, while fluid tolerance reflects the capacity to receive additional fluid without developing harmful consequences. A patient may remain fluid responsive while simultaneously demonstrating evidence of pulmonary congestion or raised cardiac filling pressures.
How fluid tolerance was measured
The trial explored whether modifying fluid doses according to intolerance signals could reduce adverse outcomes without compromising perfusion. Researchers evaluated fluid tolerance using four bedside assessments: lung ultrasound scores, venous excess ultrasound (VExUS), the E/lateral e′ ratio, a measure of cardiac function, and central venous pressure. These indicators were categorized through a color-coded system: green for safe fluid boluses, yellow for reduced doses, and red for no additional fluids. The intervention incorporated these parameters into resuscitation decisions, with patients categorized as green receiving a 500-mL bolus, yellow receiving 250 mL, and red receiving no further fluid.
Read Also: AI improves mechanical ventilation outcomes
Participants in the intervention group received smaller boluses, 250 milliliters for yellow signals and none for red, while the conventional group continued standard 500-milliliter boluses as long as signs of hypoperfusion persisted. Over six hours, the intervention group received a median of 250 milliliters per bolus, compared to 650 milliliters in the conventional group, marking a difference of roughly 500 milliliters. Despite these variations, total fluid exposure before and during the trial remained similar, indicating that the strategy primarily influenced fluid administration during the study period itself.
Study limitations and early halt
The trial initially screened 113 patients but ultimately enrolled only 36, 17 in the intervention group and 18 in the conventional care group. The small sample size restricts the reliability of the findings, though recruitment was discontinued early because further enrollment was no longer feasible. The investigators originally planned to enroll 62 patients, but logistical challenges led to an early halt in the study. Of the 113 screened, 35 were included in the final analysis, representing a substantial limitation in interpreting the results.
The primary outcome, a measure of lung oxygenation (PaO₂/FiO₂), showed a significant improvement in the intervention group, with an increase of 40.5 points, while the conventional group experienced a decline of 37.9 points. This suggests that restricting fluids based on intolerance signals may help sustain oxygenation without worsening hypoperfusion, as lactate levels and capillary refill times remained statistically unchanged between groups. Secondary assessments included changes in lactate concentration and capillary refill time, reinforcing the finding that tissue perfusion was preserved despite reduced fluid administration. The between-group median difference in PaO₂/FiO₂ was 78.3 points, with a statistically significant result (p<0.001).
